based on 3 analysts
66.67%
Buy
0.00%
Hold
33.33%
Sell
Based on 3 analysts offering long term price targets for Strides Pharma Science Ltd. An average target of ₹1373
Source: S&P Global Market Intelligence
Strides Pharma Science Ltd price forecast by 3 analysts
Upside of106.96%
High
₹1874
Target
₹1373.00
Low
₹1070
Strides Pharma Science Ltd target price ₹1373, a slight upside of 106.96% compared to current price of ₹688.4. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Strides Pharma Science Ltd revenue growth forecast
Expected growth rate Q1, FY2027:42.39%
Forecast
Actual
Including amortisation and stock based compensations
Strides Pharma Science Ltd EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -3.27 % |
3 Month Return | -57.5 % |
1 Year Return | -4.52 % |
Market Stats | |
Previous Close | ₹663.40 |
Open | ₹670.00 |
Volume | 7.40L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹6,114.07Cr |
P/E Ratio | 38.57 |
PEG Ratio | 1.75 |
Market Cap | ₹6,114.07 Cr |
P/B Ratio | 2.02 |
EPS | -4.49599698514042 |
Dividend Yield | 0.32 |
Sector | Pharmaceuticals |
ROE | 1.87 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹6,114.07 Cr | 7.48% | 0.66 | -₹95 Cr | ₹4,051 Cr | |
BUY | ₹14,414.15 Cr | 11.43% | 0.51 | NA | NA | |
NA | ₹5,045.34 Cr | -3% | 0.79 | -₹388 Cr | ₹75 Cr | |
NA | ₹547.12 Cr | -3.49% | 0.54 | NA | NA | |
NA | ₹64.67 Cr | -2.32% | 0.57 | NA | NA |
Organisation | Strides Pharma Science Ltd |
Headquarters | Bangaluru |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Strides Pharma Science Ltd
Strides Pharma Reports Strong Q3 FY25 Results - 30 Jan, 2025
Strides Pharma Reports Q2FY25 Revenue and Profit - 27 Jan, 2025
Strides Pharma Shares Surge Ahead of OneSource Listing - 23 Jan, 2025
Strides Pharma Secures USFDA Approval for Pain Relief - 20 Jan, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 10.80% to 10.86% in Dec 2024 quarter
Retail Holding Up
Retail Investor have increased holdings from 25.83% to 27.77% in Dec 2024 quarter
Price Rise
In the last 7 days, STAR stock has moved up by 15.8%
Promoter Holding Up
Promoters have increased holdings from 25.84% to 26.82% in Dec 2024 quarter
Profit Spike
Netprofit is up for the last 4 quarters, 18.18 Cr → 87.95 Cr (in ₹), with an average increase of 31.6% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 59.1% return, outperforming this stock by 63.6%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 136.2% return, outperforming this stock by 72.0%
FII Holding Down
Foreign Institutions have decreased holdings from 30.08% to 28.48% in Dec 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 1.19K Cr → 1.16K Cr (in ₹), with an average decrease of 2.9% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 26.82% | 3.81 | |
Foreign Institutions | 28.48% | ||
Mutual Funds | 10.86% | 0.57 | |
Retail Investors | 27.77% | 7.48 | |
Others | 6.07% |
Strides Pharma Science Ltd in the last 5 years
Lowest (-409.06x)
July 5, 2021
Today (38.57x)
February 3, 2025
Industry (53.65x)
February 3, 2025
Highest (6306.63x)
September 27, 2024
Strides Pharma Science Ltd’s net profit jumped 77.07% since last year same period to ₹87.95Cr in the Q3 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated 22.42% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Strides Pharma Science Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.58%.
Read More about DividendsBearish
Neutral
Bullish
Strides Pharma Science Ltd is currently in a Neutral trading position according to technical analysis indicators.
Strides Pharma Science Ltd share price today stands at ₹688.4, Open: ₹670, Previous Close: ₹663.4, High: ₹708.7, Low: ₹669, 52 Week High: ₹1675, 52 Week Low: ₹530.
Strides Pharma Science Ltd is listed on NSE
Strides Pharma Science Ltd is listed on BSE
Today's traded volume of Strides Pharma Science Ltd(STAR) is 7.40L.
Today's market capitalisation of Strides Pharma Science Ltd(STAR) is ₹6114.07Cr.
Strides Pharma Science Ltd (STAR) share price is ₹688.4. It is down -58.90% from its 52 Week High price of ₹1675
Strides Pharma Science Ltd (STAR) share price is ₹688.4. It is up 29.89% from its 52 Week Low price of ₹530
PE Ratio of Strides Pharma Science Ltd is 38.57
PE ratio = Strides Pharma Science Ltd Market price per share / Strides Pharma Science Ltd Earnings per share